Development and Validation of CCTA-based Radiomics Signature for Predicting Coronary Plaques With Rapid Progression
Circulation: Cardiovascular Imaging · 2023
DOI: 10.1161/circimaging.123.015340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2023. Verfasst von Qian Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Affiliated Jinling Hospital (Q.C., C.X.T., L.Y., P.X., L.J.Z.), Nanjing Medical University, China. Hauptthemen laut MEDLINE: Computed Tomography Angiography, Tomography, X-Ray Computed. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Rapid plaque progression (RPP) is associated with a higher risk of acute coronary syndromes compared with gradual plaque progression. We aimed to develop and validate a coronary computed tomography angiography (CCTA)–based radiomics signature (RS) of plaques for predicting RPP. METHODS: A total of 214 patients who underwent serial CCTA examinations from 2 tertiary hospitals (development group, 137 patients with 164 lesions; validation group, 77 patients with 101 lesions) were retrospectively enrolled. Conventional CCTA-defined morphological parameters (eg, high-risk plaque characteristics and plaque burden) and radiomics features of plaques were analyzed. RPP was defined as an annual progression of plaque burden ≥1.0% on lesion-level at follow-up CCTA. RS was built to predict RPP using XGBoost method. RESULTS: RS significantly outperformed morphological parameters for predicting RPP in both the development group (area under the receiver operating characteristic curve, 0.82 versus 0.74; P =0.04) and validation group (area under the receiver operating characteristic curve, 0.81 versus 0.69; P =0.04). Multivariable analysis identified RS (odds ratio, 2.35 [95% CI, 1.32–4.46]; P =0.005) as an independent predictor of subsequent RPP in the validation group after adjustment of morphological confounders. Unlike unchanged RS in the non-RPP group, RS increased significantly in the RPP group at follow-up in the whole dataset ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Affiliated Jinling Hospital (Q.C., C.X.T., L.Y., P.X., L.J.Z.), Nanjing Medical University, China.
- Department of Radiology, Nanjing First Hospital (Q.C., G.X., Y.F., Y.H., S.Z., H.X., X.Y.), Nanjing Medical University, China.
- Department of Cardiology, Nanjing First Hospital (X.G.), Nanjing Medical University, China.
- School of Public Health, Shanghai JiaoTong University School of Medicine, China (M.L.).
- Bayer Healthcare, Shanghai, China (X.T.).
ORCID-Profile: Guanghui Xie, Xiaofei Gao, Mengjie Lu, Yunlei Fu, Hui Xu, Xindao Yin, Long Jiang Zhang
Zitieren
APA
Chen, Q., Xie, G., Tang, C. X., Yang, L., Xu, P., Gao, X., Lu, M., Fu, Y., Huo, Y., Zheng, S., Tao, X., Xu, H., Yin, X., & Zhang, L. J. (2023). Development and Validation of CCTA-based Radiomics Signature for Predicting Coronary Plaques With Rapid Progression. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.123.015340
Vancouver
Chen Q, Xie G, Tang CX, Yang L, Xu P, Gao X, et al. Development and Validation of CCTA-based Radiomics Signature for Predicting Coronary Plaques With Rapid Progression. Circulation: Cardiovascular Imaging. 2023. doi:10.1161/circimaging.123.015340
BibTeX
@article{Chen2023,
author = {Chen, Qian and Xie, Guanghui and Tang, Chun Xiang and Yang, Liu and Xu, Pengpeng and Gao, Xiaofei and Lu, Mengjie and Fu, Yunlei and Huo, Yingsong and Zheng, Shaoqing and Tao, Xinwei and Xu, Hui and Yin, Xindao and Zhang, Long Jiang},
title = {Development and Validation of CCTA-based Radiomics Signature for Predicting Coronary Plaques With Rapid Progression},
journal = {Circulation: Cardiovascular Imaging},
year = {2023},
doi = {10.1161/circimaging.123.015340}
}
EUVIMED